Cerenome (CNSY) Gross Margin (2011 - 2018)
Powered by 
Analysis
Cerenome (CNSY) Gross Margin (2011 - 2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 35.86% |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 89.76% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 76.90% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 84.20% |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 26.81% |
| Jun 30, 2018 | 4.55% |
| Mar 31, 2018 | 20.79% |
| Dec 31, 2017 | 4.38% |
| Sep 30, 2017 | -4.28% |
| Jun 30, 2017 | 27.04% |
| Mar 31, 2017 | -21.15% |
| Dec 31, 2016 | 35.54% |
| Sep 30, 2016 | 15.46% |
| Jun 30, 2016 | 48.05% |
| Mar 31, 2016 | 57.46% |
| Dec 31, 2015 | 49.16% |
| Sep 30, 2015 | 34.46% |
| Jun 30, 2015 | 19.70% |
| Mar 31, 2015 | 33.81% |
| Dec 31, 2014 | 42.65% |
| Sep 30, 2014 | 34.94% |
| Jun 30, 2014 | 18.07% |
| Mar 31, 2014 | 59.17% |
| Dec 31, 2013 | 58.39% |